Project Details
Description
Efficacy- safety, and pharmacokinetics of cargrilinitide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (CagriSema) once weekly for weight management in children and adolescents with overweight or obesity
| Status | Active |
|---|---|
| Effective start/end date | 7/31/25 → 7/30/36 |
Funding
- NOVO NORDISK, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.